Aroa Biosurgery remains among top picks in medtech post Enivo clearance - Canaccord

Aroa Biosurgery

12/04/2023 20:37

** Australia's Aroa Biosurgery  ARX.AX  on Wednesday
announced it has secured U.S. FDA 510k clearance for its Enivo
pump and catheter
    ** Analysts at Canaccord Genuity say co remains one of the
top picks in medtech coverage post this update on the back of
long-term growth prospects
    ** Brokerage says that clearance helps simplify the product
commercialisation process going ahead; maintains 'Buy' rating
    ** Adds investor focus will remain on ongoing distribution
partner, U.S.-based TELA Bio's  TELA.O  performance
    ** Stock has fallen 3.2% this year, as of last close

 (Reporting by Rishav Chatterjee in Bengaluru)
 ((Rishav.Chatterjee@thomsonreuters.com;))